The Spanish version of the EuroQol: Description and applications;La versión española del EuroQol: Descripción y aplicaciones

Medicina Clinica

Volumn 112, Issue SUPPL. 1, 1999, Pages 79-86

  Badia, Xavier ^a   Roset, Montserrat ^b   Montserrat, Sara ^b   Herdman, Michael ^b   Segura, Andreu ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EUROPE; FEMALE; HUMAN; MALE; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; REVIEW; SOCIAL PSYCHOLOGY; SPAIN; UTILIZATION REVIEW;

EUROPE; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SOCIAL VALUES; SPAIN;

EID: 0006942658     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Williams A. The measurement and valuation of health: a chronicle. The University of York. Discussion Paper 136: 1-48.
2. Patrick DL, Erickson P. Theoretical foundations for health-related quality of life, 58. En: Patrick DL, editor. Health status and health policy. Allocating resources to health care. Nueva York: Oxford University Press, 1993; 58-75.
3. Alonso J, Prieto L, Antó JM. La versión española del SF-36 Health Survey (Cuestionario de Satud SF-36): un instrumento para la medida de los resultados cllnicos. Med Clin (Barc) 1995; 104: 771-776.
4. Badia X, Gutiérrez F, Wiklund I, Alonso J. Validity and reliability fo the Spanish Version of the Psychological General Well-Being Indez. Quality of Life Res 1996; 5: 101-108.
5. Badia X, Alonso J. Re-scaling the Spanish version of the Sickness Impact Profile: an opportunity for the assessment of cross-cultural equivalence. J Clin Epidemiol 1995; 48: 949-957.
6. Alonso J, Prieto L, Antó JM. The Spanish version of the Nottingham Health Profile: a review of adaptation and instrument characteristics. Quality of Life Res 1994; 3: 385-393.
7. Badia X. La medida de la calidad de vida relacionada con la salud en la evaluación económica: técnicas de obtención de preferencias de los estados de salud. En: Sacristán JA, Badia X, Rovira J, editores. Farmacoeconomía: evaluación económica de medicamentos. Madrid: Editores Médicos, S.A., 1995; 77-92.
8. EuroQol Group. EuroQol -A new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
9. Essink-Bot ML. Valuation of health states by the general public: feasibility of a standardised measurement procedure. Soc Sci Med 1990; 31: 1.201-1.206.
10. Kind P. Measuring valuations for health states: a survey of patients in general practice. York Centre for Health Economics Discussion Paper No. 76, University of York, 1990.
11. Brooks R, with the EuroQol Group. EuroQol: the current state of play. Health Policy 1996; 37: 53-72.
12. Dolan P. Modelling valuations for EQ health states. Med Care 1997; 35: 1.095-1.108.
13. Dolan P, Gudez C, Kind P, Williams A. Valuing health states: a comparison of methods. J Health Econ 1996; 15: 209-231.
14. Badia X, Fernández E, Segura A. Influence of socio-demographic and health status variables on evaluation of health states in a Spanish population. Eur J Public Health 1995; 5: 87-93.
15. Badia X, Herdman M, Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics. En prensa.
16. Badia X, Díaz-Prieto A, Rué M, Patrick DL. Measuring health and health state preferences among critically ill patients. Intens Care Med 1996; 22: 1.379-1.384.
17. Badia X, Schiaffino A, Alonso J, Herdman M. Utilidad del EuroQol 5-D en la población general de Cataluña: aplicabilidad y validez del constructo. Med Clin (Barc). En prensa.
18. Gaminde I, Cabasés J. Measuring valuations for health status amongst the general population in Navarra. En: Badia X, Herdman M, Segura A, editores. Barcelona: Proceedings of the EuroQol Meeting, 3-6 de octubre de 1995; 113-122
19. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population survey. Health Econ 1996; 5: 141-154.
20. Badia X, Sáez M, Pinto JL. Is the EuroQol data produced an interval scale? Applying the method of succesive intervals with the Spanish EuroQol data. En: O'Hanlon M, Buxton M, editores. EuroQol Plenary Meeting. Londres: Health Economics Research Group. Brunel University, 1995; 147-157.
21. Rué M, Badia X. The Spanish EuroQol tariff-, results from the Catalan Health Survey based on self-rating health. En: Badia X, Herdman M, Segura A, editores. Barcelona: Proceedings of the EuroQol Meeting, 3-6 de octubre de 1995; 77-98.
22. Elvik R. The validity of using health state indexes in measuring the consequences of traffic injury for public health. Soc Sci Med 1995; 40: 1.395-1.398.
23. Essink-Bot ML, Van Roijen L, Krabbe PFM, Bonsel GJ, Rutten FFH. The impact of migraine on health status. Headache 1995; 35: 200-206.
24. Hurst N, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 6: 551-559.
25. Wu AW, Jacobson DL, Berzon RA, Revicki DA, Horst C VD, Fichtenbaum CJ et al. The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Qual Life Res 1997; 6: 3-10.
26. Van Busschbach J, Brouwer WBF, Van der Donk A, Passchier J, Rutten FFH. An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease. Pharmacoeconomics 1998; 13: 21-34.
27. James M, St Leger S, Rowsell KV. Prioritising elective care: a cost utility analysis of orthopaedics in the north west of England. J Epidemiol Commun Health 1996; 50: 182-189.
28. Nord E, Wisloff F, Hjorth M. Cost-utility analysis of melphalan plus prednisone with or without Interferon alfa-2b in newly diagnosed multiple myeloma. Pharmacoeconomics 1997; 12: 89-103.
29. Gold MR, Patrick DL, Torrance GW, Fryback DG, Hadorn DC, Kamlet MS et al. Identifying and valuing outcomes. En: Gold MR, Siegel JE, Russell LB, Weinstein MC, editores. Cost-effectiveness in health and medicine. Nueva York: Oxford University Press, 1996; 96-120.
30. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population survey. Health Economics 1996; 5: 141-154.